Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis.
Binks SNM., Veldsman M., Handel AE., Jacob S., Maddison P., Coebergh J., Michael S., Ramanathan S., Easton A., Nissen MS., Leite MI., Okai D., Blaabjerg M., Husain M., Irani SR.
Patient-reported quality-of-life (QoL) and carer impacts are not reported after leucine-rich glioma-inactivated 1-antibody encephalitis (LGI1-Ab-E). From 60 patients, 85% (51 out of 60) showed one abnormal score across QoL assessments and 11 multimodal validated questionnaires. Compared to the premorbid state, QoL significantly deteriorated (p